Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Repurchased: 2013-2025

Historic Shares Repurchased for Amphastar Pharmaceuticals (AMPH) over the last 10 years, with Sep 2025 value amounting to $4.8 million.

  • Amphastar Pharmaceuticals' Shares Repurchased fell 86.13% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.1 million, marking a year-over-year increase of 4.26%. This contributed to the annual value of $85.5 million for FY2024, which is 46.98% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Shares Repurchased stood at $4.8 million for Q3 2025, which was down 87.63% from $39.2 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Shares Repurchased high stood at $50.0 million for Q3 2023, and its period low was $128,000 during Q2 2023.
  • For the 3-year period, Amphastar Pharmaceuticals' Shares Repurchased averaged around $23.8 million, with its median value being $23.0 million (2024).
  • The largest annual percentage gain for Amphastar Pharmaceuticals' Shares Repurchased in the last 5 years was 552.16% (2023), contrasted with its biggest fall of 97.91% (2023).
  • Quarterly analysis of 5 years shows Amphastar Pharmaceuticals' Shares Repurchased stood at $13.4 million in 2021, then soared by 34.48% to $18.1 million in 2022, then soared by 244.98% to $50.0 million in 2023, then plummeted by 30.09% to $42.0 million in 2024, then slumped by 86.13% to $4.8 million in 2025.
  • Its Shares Repurchased was $4.8 million in Q3 2025, compared to $39.2 million in Q2 2025 and $11.0 million in Q1 2025.